Literature DB >> 29634663

Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment.

Vasilios Kotsis1, Jens Jordan2, Dragan Micic3, Nicholas Finer4, Deborah R Leitner5, Hermann Toplak5, Lale Tokgozoglu6, Vasilios Athyros7, Moses Elisaf8, Theodosios D Filippatos9, Josep Redon10,11, Pau Redon10, Christina Antza1, Konstantinos Tsioufis12, Guido Grassi13,14, Gino Seravalle15, Antonio Coca16, Cristina Sierra16, Empar Lurbe17,18, Stella Stabouli19, Bojan Jelakovic20, Peter M Nilsson21.   

Abstract

: Obesity is a key factor for cardiovascular diseases and complications. Obesity is associated with hypertension, dyslipidemia and type II diabetes, which are the major predictors of cardiovascular disease in the future. It predisposes for atrial fibrillation, heart failure, sudden cardiac death, renal disease and ischemic stroke that are the main causes of cardiovascular hospitalization and mortality. As obesity and the cardiovascular effects on the vessels and the heart start early in life, even from childhood, it is important for health policies to prevent obesity very early before the disease manifestation emerge. Key roles in the prevention are strategies to increase physical exercise, reduce body weight and to prevent or treat hypertension, lipids disorders and diabetes earlier and efficiently to prevent cardiovascular complications.Epidemiology and mechanisms of obesity-induced hypertension, diabetes and dyslipidemia will be reviewed and the role of lifestyle modification and treatment strategies in obesity will be updated and analyzed. The best treatment options for people with obesity, hypertension, diabetes and dyslipidemia will discussed.

Entities:  

Mesh:

Year:  2018        PMID: 29634663     DOI: 10.1097/HJH.0000000000001730

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  23 in total

Review 1.  Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review.

Authors:  Jeffrey I Mechanick; Michael E Farkouh; Jonathan D Newman; W Timothy Garvey
Journal:  J Am Coll Cardiol       Date:  2020-02-11       Impact factor: 24.094

2.  Supplementation With the Sialic Acid Precursor N-Acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension.

Authors:  Jun Peng; Wanpen Vongpatanasin; Anastasia Sacharidou; Domagoj Kifer; Ivan S Yuhanna; Subhashis Banerjee; Keiji Tanigaki; Ozren Polasek; Haiyan Chu; Nathan C Sundgren; Anand Rohatgi; Ken L Chambliss; Gordan Lauc; Chieko Mineo; Philip W Shaul
Journal:  Circulation       Date:  2019-10-10       Impact factor: 29.690

3.  General obesity, abdominal adiposity, and the risk of incident hypertension-From anthropometry to modern imaging techniques.

Authors:  Panagiotis I Georgianos; Pantelis E Zebekakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10       Impact factor: 3.738

Review 4.  Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

Authors:  T D Filippatos; K Alexakis; V Mavrikaki; D P Mikhailidis
Journal:  Dig Dis Sci       Date:  2021-01-19       Impact factor: 3.199

5.  Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study.

Authors:  Tong Liu; Zheng Wu; Jinghua Liu; Yun Lv; Wenzheng Li
Journal:  Cardiovasc Diabetol       Date:  2021-05-10       Impact factor: 9.951

6.  Development of a risk prediction model for incident hypertension in Japanese individuals: the Hisayama Study.

Authors:  Emi Oishi; Jun Hata; Takanori Honda; Satoko Sakata; Sanmei Chen; Yoichiro Hirakawa; Daigo Yoshida; Mao Shibata; Tomoyuki Ohara; Yoshihiko Furuta; Takanari Kitazono; Toshiharu Ninomiya
Journal:  Hypertens Res       Date:  2021-05-31       Impact factor: 3.872

7.  Association of mammographic density and benign breast calcifications individually or combined with hypertension, diabetes, and hypercholesterolemia in women ≥40 years of age: a retrospective study.

Authors:  Maha Al-Mohaissen; Arwa Alkhedeiri; Ohoud Al-Madani; Terry Lee; Anas Hamdoun; Mohammad Al-Harbi
Journal:  J Investig Med       Date:  2022-02-21       Impact factor: 3.235

8.  Evaluation of Clinical Factors Predictive of Diabetes Remission Following Bariatric Surgery.

Authors:  Isabel Mateo-Gavira; Esteban Sánchez-Toscano; Mª Ángeles Mayo-Ossorio; José Manuel Pacheco-García; Jose Arturo Prada-Oliveira; Francisco Javier Vílchez-López
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

9.  Identifying the Impact of Metabolic Syndrome in Hypertensive Patients.

Authors:  Luiz Aparecido Bortolotto
Journal:  Arq Bras Cardiol       Date:  2018-06       Impact factor: 2.000

10.  The effect of obesity on periodontitis progression: the 10-year retrospective cohort study.

Authors:  Apinun Charupinijkul; Sirikarn Arunyanak; Sasivimol Rattanasiri; Prin Vathesatogkit; Lalitsara Thienpramuk; Attawood Lertpimonchai
Journal:  Clin Oral Investig       Date:  2021-06-28       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.